Published in Stroke on August 02, 2007
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm. Acta Neurochir Suppl (2011) 1.32
Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl (2008) 1.28
Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke (2008) 1.25
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis (2008) 1.17
Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain (2009) 1.15
Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. J Rare Disord (2013) 1.12
Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke (2012) 1.08
Brain reorganization after endovascular treatment in a patient with a large arteriovenous malformation: the role of diagnostic and functional neuroimaging techniques. Interv Neuroradiol (2013) 1.04
Biology of cerebral arteriovenous malformations with a focus on inflammation. J Cereb Blood Flow Metab (2014) 1.03
Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis. Am J Pathol (2009) 0.95
Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology (2014) 0.94
Gene expression profiling of blood in brain arteriovenous malformation patients. Transl Stroke Res (2011) 0.90
Population stratification in a case-control study of brain arteriovenous malformation in Latinos. Neuroepidemiology (2008) 0.89
EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations. Circ Cardiovasc Genet (2009) 0.88
Case report of a de novo brainstem arteriovenous malformation in an 18-year-old male and review of the literature. Neurosurg Rev (2014) 0.87
Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res (2014) 0.86
Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms. J Neurol Neurosurg Psychiatry (2014) 0.85
Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations. Cerebrovasc Dis (2011) 0.84
Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery (2007) 0.84
Influence of patient age on angioarchitecture of brain arteriovenous malformations. AJNR Am J Neuroradiol (2014) 0.83
Endothelial signaling and the molecular basis of arteriovenous malformation. Cell Mol Life Sci (2013) 0.79
G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation. Transl Stroke Res (2012) 0.77
The role of microsurgical resection and radiosurgery for cerebral arteriovenous malformations. Methodist Debakey Cardiovasc J (2015) 0.77
Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients. PLoS One (2017) 0.75
When race/ethnicity matters more than size. Stroke (2007) 0.75
Animal Models in Studying Cerebral Arteriovenous Malformation. Biomed Res Int (2015) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med (2010) 8.28
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol (2006) 8.02
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol (2004) 3.82
Improved blood pressure control associated with a large-scale hypertension program. JAMA (2013) 3.80
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg (2006) 3.73
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke (2007) 3.36
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr (2002) 3.33
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol (2012) 3.23
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA (2003) 2.93
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Ethics and sample size. Am J Epidemiol (2005) 2.88
Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron (2003) 2.81
Maintaining a high physical activity level over 20 years and weight gain. JAMA (2010) 2.78
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71
A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med (2013) 2.70
Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68
Epidemiology of menthol cigarette use. Nicotine Tob Res (2004) 2.66
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke (2009) 2.55
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med (2008) 2.49
The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol (2006) 2.44
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol (2007) 2.38
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke (2004) 2.37
Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation (2005) 2.36
Alcohol consumption, binge drinking, and early coronary calcification: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (2005) 2.35
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol (2002) 2.34
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Immigration and acculturation in relation to health and health-related risk factors among specific Asian subgroups in a health maintenance organization. Am J Public Health (2004) 2.26
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Idiopathic intracranial hypertension. Neurosurgery (2004) 2.21
Ultrasound visibility of needles used for regional nerve block: an in vitro study. Reg Anesth Pain Med (2004) 2.19
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Self-reported experiences of racial discrimination and Black-White differences in preterm and low-birthweight deliveries: the CARDIA Study. Am J Public Health (2004) 2.17
Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med (2012) 2.14
Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care (2004) 2.12
Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke (2003) 2.12
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07